Stay updated on Avelumab in 3rd-Line Gastric Cancer Clinical Trial

Sign up to get notified when there's something new on the Avelumab in 3rd-Line Gastric Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Avelumab in 3rd-Line Gastric Cancer Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    Gastric cancer was added to the conditions section and the Genetic and Rare Diseases Information Center resource was included under resources; the page revision was updated from v3.4.1 to v3.4.2.
    Difference
    0.1%
    Check dated 2026-02-15T03:16:10.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    Revision updated from v3.4.0 to v3.4.1; no observable changes to study details or listed information.
    Difference
    0.0%
    Check dated 2026-02-08T03:11:51.000Z thumbnail image
  4. Check
    31 days ago
    Change Detected
    Summary
    Added a Show glossary option and new metadata items (Last Update Submitted that Met QC Criteria; No FEAR Act Data; Revision: v3.4.0). Removed the previous metadata entries (Last Update Submitted that met QC Criteria; No FEAR Act data; Revision: v3.3.4).
    Difference
    0.1%
    Check dated 2026-01-24T22:32:07.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    Revision updated from v3.3.3 to v3.3.4; no user-facing study details or sections appear to be affected. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-18T00:39:13.000Z thumbnail image
  6. Check
    66 days ago
    Change Detected
    Summary
    Locations section updated with an expanded list of sites across numerous states and countries; older location blocks were removed and the revision is v3.3.3.
    Difference
    2%
    Check dated 2025-12-20T19:19:16.000Z thumbnail image
  7. Check
    89 days ago
    Change Detected
    Summary
    Revision: v3.3.2 is now displayed, replacing the previous v3.3.1.
    Difference
    0.0%
    Check dated 2025-11-28T01:43:43.000Z thumbnail image

Stay in the know with updates to Avelumab in 3rd-Line Gastric Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Avelumab in 3rd-Line Gastric Cancer Clinical Trial page.